Novo Nordisk Gains EU Approval for Higher-Dose Weight-Loss Treatment
The European Commission has granted Novo Nordisk authorization to market a higher maintenance dose of its anti-obesity medication,…
Novo Nordisk Gains Strategic Edge with Higher-Dose Wegovy Approval
Novo Nordisk has secured a significant regulatory endorsement from European authorities, providing a timely boost for its obesity…
Novo Nordisk Gains EU Approval for Higher-Dose Weight Loss Treatment
Novo Nordisk has secured a significant regulatory endorsement in Europe for its obesity medication, Wegovy. The European Commission…